Fig. 3 | British Journal of Cancer

Fig. 3

From: The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Fig. 3

Kaplan–Meier curve for PFS and OS according to PIV and treatment arm in the Valentino study (a and b, respectively) and in the TRIBE study (c and d, respectively). PIV was not significantly associated with a differential effect of the two maintenance arms in the Valentino study nor with a differential effect of triplet-based vs doublet-based therapy in the TRIBE study.

Back to article page